Literature DB >> 23360288

Mitochondria in cancer stem cells: a target for therapy.

Rute Loureiro1, Katia A Mesquita, Paulo J Oliveira, Ignacio Vega-Naredo.   

Abstract

Complete knowledge about the evolution of the carcinogenic process has to include cancer stem cells (CSCs), which are essential to understand tumor occurrence, recurrence, and also its reduction rate after radio- and/or chemotherapeutic treatments. Understanding CSCs physiology and metabolism may be crucial for the development of novel effective therapies. Therefore, being mitochondria an undeniable target for cancer therapy and a central hub in metabolism and cell and death decisions, it is essential to take this organelle into account and explore its actions and involvements in the context of CSCs physiology. In this review, we focus on recent patents and discoveries about mitochondrial bioenergetics and physiology of CSCs. A full understanding of the role of mitochondrial activity in CSCs and the creation of new strategies, methods and discoveries to support actual treatments with novel ones are of pivotal importance in order to ultimately eradicate cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23360288     DOI: 10.2174/18722148113079990006

Source DB:  PubMed          Journal:  Recent Pat Endocr Metab Immune Drug Discov        ISSN: 1872-2148


  18 in total

Review 1.  Metabolic modulation of cancer: a new frontier with great translational potential.

Authors:  Adam Kinnaird; Evangelos D Michelakis
Journal:  J Mol Med (Berl)       Date:  2015-01-14       Impact factor: 4.599

Review 2.  Prevention of breast cancer by dietary polyphenols-role of cancer stem cells.

Authors:  Hao-Feng Gu; Xue-Ying Mao; Min Du
Journal:  Crit Rev Food Sci Nutr       Date:  2019-01-11       Impact factor: 11.176

Review 3.  Mitochondria as therapeutic targets for cancer stem cells.

Authors:  In Sung Song; Jeong Yu Jeong; Seung Hun Jeong; Hyoung Kyu Kim; Kyung Soo Ko; Byoung Doo Rhee; Nari Kim; Jin Han
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

4.  Mitochondrial metabolism directs stemness and differentiation in P19 embryonal carcinoma stem cells.

Authors:  I Vega-Naredo; R Loureiro; K A Mesquita; I A Barbosa; L C Tavares; A F Branco; J R Erickson; J Holy; E L Perkins; R A Carvalho; P J Oliveira
Journal:  Cell Death Differ       Date:  2014-05-16       Impact factor: 15.828

5.  Induction of apoptosis by total flavonoids from Scutellaria barbata D. Don in human hepatocarcinoma MHCC97-H cells via the mitochondrial pathway.

Authors:  Jie Gao; Wang-Feng Lu; Zhi-Jun Dai; Shuai Lin; Yang Zhao; Sha Li; Nuan-Nuan Zhao; Xi-Jing Wang; Hua-Feng Kang; Xiao-Bin Ma; Wang-Gang Zhang
Journal:  Tumour Biol       Date:  2013-11-13

6.  Common Metabolic Pathways Implicated in Resistance to Chemotherapy Point to a Key Mitochondrial Role in Breast Cancer.

Authors:  Etna Abad; Yoelsis García-Mayea; Cristina Mir; David Sebastian; Antonio Zorzano; David Potesil; Zbynek Zdrahal; Alex Lyakhovich; Matilde E Lleonart
Journal:  Mol Cell Proteomics       Date:  2018-10-29       Impact factor: 5.911

7.  Melatonin antiproliferative effects require active mitochondrial function in embryonal carcinoma cells.

Authors:  Rute Loureiro; Silvia Magalhães-Novais; Katia A Mesquita; Ines Baldeiras; Isabel S Sousa; Ludgero C Tavares; Ines A Barbosa; Paulo J Oliveira; Ignacio Vega-Naredo
Journal:  Oncotarget       Date:  2015-07-10

8.  Cabozantinib and Vandetanib in medullary thyroid carcinoma: mitochondrial function and its potential as a therapeutic target towards novel strategies to design anti-CSCs drugs.

Authors:  Ekaterini Christina Tampaki; Athanasios Tampakis; Raoul Droeser; Efstratios Patsouris; Gregory Kouraklis
Journal:  Cancer Biol Ther       Date:  2018-08-17       Impact factor: 4.742

9.  Successful Treatment of Intracranial Glioblastoma Xenografts With a Monoamine Oxidase B-Activated Pro-Drug.

Authors:  Martyn A Sharpe; Andrew D Livingston; Taylor L Gist; Pardip Ghosh; Junyan Han; David S Baskin
Journal:  EBioMedicine       Date:  2015-08-08       Impact factor: 8.143

Review 10.  Polyphenols as Modulator of Oxidative Stress in Cancer Disease: New Therapeutic Strategies.

Authors:  Anna Maria Mileo; Stefania Miccadei
Journal:  Oxid Med Cell Longev       Date:  2015-11-16       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.